Table 3.

How and when to test for sexually transmitted infections in men who have sex with men

INFECTIONHOW TO TESTWHEN TO TESTCONSIDERATIONS
Gonorrhea or chlamydia1,3
  • First-catch urine

At presentation
  • Sensitivity: 97%-100%

  • Swabs:

    • - Pharynx

    • - Internal genitals, front holes, neovaginas

    • - Rectum

At presentation
  • Use NAAT

  • Sensitivities: 96%-100%

  • Testing can be done immediately after exposure

Syphilis1,3,15
  • Serology

  • At presentation

  • ≥4 wk from potential exposure

  • Repeat every 3 mo if ongoing risk

  • EIA screen, with or without RPR and TPPA assay

  • Sensitivity:

    • - 75% in primary infection

    • - 98%-100% in secondary infection

  • DFA or PCR test

At presentation when lesions are present
  • Sensitivity: 73%-100%

  • Can detect only in primary and secondary infection

Herpes simplex virus1,3SwabsAt presentation
  • Sensitivity:

    • - 94% for vesicles

    • - 87% for pustular lesions

    • - 70% for ulcers

  • Sensitivity decreases as time from onset to specimen collection increases

HIV1,4Serology
  • At presentation

  • ≥6 wk from potential exposure

  • Repeat every 3 mo if ongoing risk

  • Fourth-generation antigen and antibody test

  • Sensitivity: 99.9%

Mpox5,27
  • Swabs:

    • - Lesions

    • - Pharynx

    • - Rectum

At presentation
  • Sensitivity:

    • - 85%-90% for lesions

    • - 60%-70% for pharynx

    • - 40%-50% for serology

  • Swab pharynx only when asymptomatic contact or lesions cannot be swabbed

  • Serology

At presentation
  • Sensitivity: 40%-50%

  • Do serology only when asymptomatic contact or lesions cannot be swabbed

Enteric bacteria and protozoa6,7
  • Culture for enteric organisms

  • Ova and parasite test for protozoa

At presentation
  • Test only if symptomatic

  • 2-3 ova and parasite test specimens are required in low-prevalence settings

  • DFA—direct fluorescent antibody, EIA—enzyme immunoassay, NAAT—nucleic acid amplification test, PCR—polymerase chain reaction, RPR—rapid plasma reagin, TPPA—Treponema pallidum passive particle agglutination.